Value of Treatment Report 2017

26th July 2017

“The Care Pathway for most European people with headache is a series of dead ends.”

“Headaches are often trivialized as “normal” and seen in those who complain of them as merely an excuse to avoid responsibility.”

“Governments, even if aware of it, do not acknowledge the substantial burden of headache on society”

“Despite the recognition of the importance of the primary care setting for treating headache, there is a knowledge gap among health-care providers and worldwide only four hours are committed to headache disorders in formal undergraduate medical training lasting 4-6 years.”

Some of the key findings from the Value of Treatment Report from the European Brain Council who launched the initial findings from Phase 2 in Brussels last month. The report recommends a headache pathway to care programme which recognises the importance of treating headache in the primary care setting, to reduce the burden on specialist clinics and also highlights the pivotal importance of community pharmacists in providing advice and support to those who suffer headache disorders.

You can now read the full report at http://bit.ly/2tllESi or view the summary poster for the headache case study here, http://bit.ly/2rgVsHS

For a summary of the key findings and recommendations from the report please visit our website here http://bit.ly/2tCqcV9

Value of Treatment Report 2017

26th July 2017

“The Care Pathway for most European people with headache is a series of dead ends.”

“Headaches are often trivialized as “normal” and seen in those who complain of them as merely an excuse to avoid responsibility.”

“Governments, even if aware of it, do not acknowledge the substantial burden of headache on society”

“Despite the recognition of the importance of the primary care setting for treating headache, there is a knowledge gap among health-care providers and worldwide only four hours are committed to headache disorders in formal undergraduate medical training lasting 4-6 years.”

Some of the key findings from the Value of Treatment Report from the European Brain Council who launched the initial findings from Phase 2 in Brussels last month. The report recommends a headache pathway to care programme which recognises the importance of treating headache in the primary care setting, to reduce the burden on specialist clinics and also highlights the pivotal importance of community pharmacists in providing advice and support to those who suffer headache disorders.

You can now read the full report at http://bit.ly/2tllESi or view the summary poster for the headache case study here, http://bit.ly/2rgVsHS

For a summary of the key findings and recommendations from the report please visit our website here http://bit.ly/2tCqcV9